Long-term observation after transjugular intrahepatic portosystemic stent-shunt in two patients with hepatocellular carcinoma.
Two patients with hepatocellular carcinoma (HCC) were treated with transjugular intrahepatic portosystemic stent-shunt (TIPS) and followed for 22 and 58 months thereafter. HCC was well controlled by transcatheter arterial chemoembolization. Hepatic failure or metastasis, especially in the lung, was not observed in the long-term observation. TIPS seems to be useful even in patients with HCC, provided HCC is controlled.
Tazawa
J
J
Department of Internal Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Tuchiura City, Japan. tzw-j@mwb.biglobe.ne.jp
Sakai
Y
Y
Yamane
M
M
Kakinuma
S
S
Maeda
M
M
Suzuki
K
K
Miyasaka
Y
Y
Nagayama
K
K
Kusano
F
F
Sato
C
C
D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000150:complications*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology / Q000601:surgery*; D008113:Liver Neoplasms / Q000150:complications*; D008297:Male; D008875:Middle Aged; D019168:Portasystemic Shunt, Transjugular Intrahepatic; D013997:Time Factors